Nigeria, Clinton Foundation in deal to fight AIDS Mon Jul 17, 2:25 PM ET
ABUJA (Reuters) - An AIDS charity set up by former U.S. President Bill Clinton signed a deal with Nigeria on Monday to make cheap AIDS drugs available to fight the disease in Africa's most populous nation.
ADVERTISEMENT
The signing was witnessed by Clinton, who said that testing for HIV/AIDS was crucial to curbing the infection rate in Nigeria, where about 3 million people are living with the virus.
"It is because 90 percent of people who are infected do not know their HIV status ... that is why it is spreading in Africa," Clinton said.
The former U.S. president said many people do not go for HIV testing because they are afraid of discrimination.
Nigeria said the agreement would help expand access to treatment for children, and raise funds to fight AIDS in Nigeria, which has the third highest case load in the world after South Africa and India.
Nigeria failed to meet targets on drug access and transparency in handling AIDS donations, prompting a major donor, the Global Fund to Fight AIDS, Tuberculosis and Malaria, to suspend about $50 million in assistance in April.
Since leaving the White House Clinton has devoted much of his attention to getting anti-AIDS drugs to poor countries at the cheapest possible prices through the foundation.
The foundation provides AIDS drugs to more than 250,000 patients through special deals with generic drug makers.
Nigeria has about 74 treatment centers where it gives out free AIDS drugs to about 40,000 patients, with plans to expand the therapy to more of those who cannot afford it.
The Global Fund suspended two five-year grants to Nigeria after just two years because of low numbers of people on treatment and concerns over data accuracy.
-------------------- Just the facts, ma'am. Posts: 1083 | From: New Jersey | Registered: Mar 2005
| IP: Logged |
the best news we can get is the closeing of thenloan for 8.2million, for the short term future
I have heard that they are breaking ground for the new site and I will talk to steve about that today.
I have heard that they are in production and they are wharehousing product the big problem is distrubution at this point. and they are working on that.
The new site I have heard to expand manufacturing will not be completed for 6 to 9 months and we will not get cash flow figures for another 4 to 5 months at a best guess.
In my personal opinion after looking things over the stock is worth about 4 to 6 cents a share not counting news pr's that could cause a spike.IMHO
The loan is looking very positive if not and it goes south they have other means to raise money but the loan is the best for investor's.
Posts: 6008 | From: phoenix az | Registered: Mar 2005
| IP: Logged |
posted
Steve did not return my call Pandey is due back today I think news next week and I still stand by my thoughts
Posts: 6008 | From: phoenix az | Registered: Mar 2005
| IP: Logged |
posted
agree, this week volume was low and stock bounced off technicals. Look for xkem to move next week, have a good weekend all
Posts: 3086 | From: miami | Registered: Nov 2005
| IP: Logged |
quote:Originally posted by phone_man: The prices for NICOSAN are published on the website now. Posting the link in case some were not aware. http://www.xechemnigeria.org/products.htm
Interesting development, could imply a few things...
Posts: 3086 | From: miami | Registered: Nov 2005
| IP: Logged |
New treatment in Nigeria Nicosan (or Hemoxin), previously Niprisan or Nix-0699, a phytochemical (ethanol/water extract of Piper guineenses seeds, Pterocapus osum stem, Eugenia caryophyllum fruit, and Sorghum bicolor leaves) was developed by Nigerian scientists in Nigeria by the National Institute for Pharmaceutical Research and Development (NIPRD) (U.S. Patent # 5,800,819 - September 1, 1998). NIPRD has already conducted Phase I, Phase IIa and IIb clinical trials and is currently conducting Phase III clinical trials in Nigeria.
A Phase IIb trial of Nicosan conducted at an army base hospital in Yaba, Lagos, Nigeria between 1996 and 1997 resulted in 73% of the 30 patients who participated in the study experiencing no crisis during the 12 month trial period and the remaining 27% experienced less frequent and less severe crises.[1]
In August 2002, Xechem International (XKEM/OTC:BB), a New Jersey company, acquired the exclusive world-wide rights to Niprisan (later re-named Nicosan/Hemoxin). On July 6, 2006 the drug was offically launched in Nigeria, with the President of Nigeria, Olusegun Obasanjo, personally in attendance.
The drug has begun with limited production, although it is expected that production will expand to meet demand. The company's website in Nigeria is http://www.xechemnigeria.com
Xechem International is currently in the process of preparing an Investigational New Drug (IND) Application for Nicosan/Hemoxin for submission to the United States Food and Drug Administration (FDA) and applicable EU agencies. Nicosan/Hemoxin has received orphan drug status in the USA and Europe
Posts: 6008 | From: phoenix az | Registered: Mar 2005
| IP: Logged |
posted
By: rocketman99fl 22 Jul 2006, 01:55 AM EDT
_______RESEARCH/DD $0.26/SHR________
Conservative DD.
XKEM [Xechem Intl] Has a drug that treats Sickle Cell Disease SCD, led by CEO Dr. Ramesh Pandey they will be the next big thing in Pharma. Nigerian Government fully Behind XKEM 100% and XKEM has recently received Orphan Status.
In Nigeria alone, there are 4,000,000 SCD patients.
NICOSAN™ $20/month = $240/year
$240 x 4,000,000 SCD patients = $960,000,000 US dollars a YEAR.
Lets assume 20% margins on Drug Sales. [its cheap to run business in Nigeria]
Earnings = $ 192 Million a Year on 960mln Revenue.
Price-Earnings Ratio - P/E Ratio
192mln will be .13 cents earnings per year profit.
PE of 20 Gives Us $2.60 potential on conservative estimates on 4 Million Nigerian SCD Patients. Divide that By 4 for 1 Million of the 4 Million Patients and you get $.65 Value for XKEM conservatively.
The P/E is sometimes referred to as the "multiple", because it shows how much investors are willing to pay per dollar of earnings. If a company were currently trading at a multiple (P/E) of 20, the interpretation is that an investor is willing to pay $20 for $1 of current earnings. PE is also the growth ratio. 20% is conservative for XKEM, it should be 40 but we will be conservative for this estimate execercise, you make your own projections.
Now lets take BRISTOL MYERS SQIBB (BMY) The have a P/E of 15.55 and a market CAP of 49 Billion $$$.
BMY is the company XKEM won a 4 Million Dollar law suit against.
Now let's say they only get to sell to 10% of the 4 Million SCD Sufferers in Nigeria.
10% of $2.60 = $.26cents
But lets not forget the FDA Orphan status and Worldwide Potential here and add the the rest of Africa (another 5 million cases)
$.26 minimum (10% of SCD sufferers Treated) can turn into over $2.00 if more than 10% are treated and Nicosan goes Worldwide. America, China, Europe.
Shorterm 0.25c [3-6 Weeks]
Longterm Target $2.00-2.50 [6-12 Months]
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Good going Juice,looks good to me and the person put some thought into that I like it.Much better than mine
I am sure glad to have this week behind me it was one to remember what a fight now I know that there is good things coming to xkem starting next week and Dr. Pandey is back now so we will start to see some pr's and I think a much better pps.
Maybe we can start to talk to Dr. Pandey about pr's Steve just does not see the importance of them. Don't have to be fluff just informative with a little sales manship in them. I don't think steve could sell a heater to an eskimo
Posts: 6008 | From: phoenix az | Registered: Mar 2005
| IP: Logged |
posted
I didnt get in on XKEM thinking it was too late so i just looked the other way got my eye on DTGP take a look at this one guys get in early get in often
-------------------- a huge fortune will arrive to you once again! Posts: 657 | From: brooklyn | Registered: Jun 2006
| IP: Logged |
posted
now and then i'll drop in subpennyradio.com and they like this stock saying as long as it stays above .0300 should be good to go. that's sounding about right -- liking how 50 is holding up imho. glta!
This one seems updated. Its amazing how he comes to $.26 if they just do 10% of the potential out there. 100% would be $2.60 on a conservative growth rate for Nigeria alone. Nigeria is 4million of the 17Million Potential Worldwide. Glad I have been buying this stock on the profit taking from .11 down to .03-.04.
Personal target is .40-.50 Longterm (couple months).
Posts: 604 | Registered: Aug 2005
| IP: Logged |
posted
it's a good thing we still have MM QUIN at the ask at 0.08 . Let see what happen this week good luck guys.
Posts: 4112 | Registered: Jun 2006
| IP: Logged |
posted
XKEM no PR's till August IMHO. We have enough PR's in the form of very informative Articles to sustain a .10+ price over the next few weeks.
Posts: 604 | Registered: Aug 2005
| IP: Logged |
quote:Originally posted by JL: XKEM no PR's till August IMHO. We have enough PR's in the form of very informative Articles to sustain a .10+ price over the next few weeks.
why you are saying no pr's comming this week ???
Posts: 4112 | Registered: Jun 2006
| IP: Logged |
quote:Originally posted by JL: XKEM no PR's till August IMHO. We have enough PR's in the form of very informative Articles to sustain a .10+ price over the next few weeks.
why you are saying no pr's comming this week ???
I actually agreee with JL plus he has a good reputation around here i've followed a few of his plays on hot stocks branch of website. the article found this weekend had plenty of great details...could be just what the doctor ordered (pun intended)
Posts: 3086 | From: miami | Registered: Nov 2005
| IP: Logged |
quote:Originally posted by dollar13: i will take JL POST as his personal opinion maybe he doesn't know what is going on.
Ive been following XKEM for a good 3-4 Months. If you read the article you should have plenty of News to last you a good amount of time. Like I said the Article has enough to feed many mouths for a long time. Maybe if you actually read it...you would realise the potency and so would your investment account realise some gains. GLTY
Posts: 604 | Registered: Aug 2005
| IP: Logged |
posted
By: foxwoodsfannh 24 Jul 2006, 09:17 AM EDT Msg. 85502 of 85502 Jump to msg. # XeChem Revenue
This is a portion of an artice from 7/16/06....
" It should be noted that NICOSAN is the first drug to be developed out of indigenous knowledge and undergoing rigorous laboratory research leading to patent award. It is also the first drug to be exported from Nigeria to other parts of world. According to Dr. Ramish Paney, the Chairman of XECHEM, it is expected to earn the country about $150 million per annum. "
If the Nigerian expected earnings from NICOSAN sales is 150 mil. per year based on a 7.5% cut, that makes the overall revenue from sales 2 BILLION per year....
Find me another stock trading at less than .05 per share with an imminent 2 BILLION per year revenue base....
Happy Hunting!
Posts: 6008 | From: phoenix az | Registered: Mar 2005
| IP: Logged |
posted
according to the chart paople just a few days of this and if we ca hold at .03 we will start a reversal
Posts: 6008 | From: phoenix az | Registered: Mar 2005
| IP: Logged |
posted
that's the way it looks to me also bond006. I'm back in and let's hope it holds. Posts: 889 | From: Corona, CA | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
